Medical Device News Magazine

Sonion Announces New CEO & President: Niels Svenningsen

Niels Svenningsen to Further Develop Sonion's Position in the Current Market and Develop New Product

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Sonion today announces the appointment of Niels Svenningsen as CEO & President of the Sonion Group. Niels Svenningsen was most recently President of Northern Europe in Schneider Electric and brings a wealth of commercial and management experience acquired in the IT and technology sectors. He will start in his new position on March 1st, 2020.

“We look very much forward to welcoming Niels. He brings an extensive commercial and general management experience to Sonion. We expect Niels to further develop our strong position of Sonion in the current market and develop new products to serve the potential of adjacent markets.” says Walther Thygesen, Chairman of the Sonion Board.

Niels Svenningsen (55 years old) was President of Northern Europe in Schneider Electric (2015-2019) and before that CEO of GN NetCom (2013-2015). Niels also has extensive experience with Sales and Marketing from large IT companies such as Hitachi Data Systems (2007-2013; Senior Vice President & General Manager EMEA 2011-2013), Hewlett Packard (Managing Director, Enterprise & Major Accounts 2002-2004; Sales Director 1996-2000) and IBM Denmark (1988-1996).

”I am very happy to be joining Sonion. This is a global company, well run and with a lot of potential, operating in an attractive market for high-tech medical components. I look forward to – together with the Sonion management team – taking Sonion further on its growth journey and exploring new attractive opportunities on the market.” says Niels Svenningsen.

Sonion is a global leader in the development and manufacturing of micro acoustic and micro mechanical solutions for hearing instruments, high-end hearables, and in-ear earphones. Sonion is owned by Novo Holdings A/S, the holding company within the Novo Group that manages the assets of the Novo Nordisk Foundation.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”